Veterinary Medicines

Benazepril hydrochloride Le Vet 20 mg tablets for dogs

Authorised
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
Benazepril hydrochloride Le Vet 20 mg tablets for dogs
Benakor vet. 20 mg tabletter til hund
Active substance:
  • Benazepril hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    20.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Carton box containing 5 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 6 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 5 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 2 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 1 PVC-PE-PVDC-Alu-foil blisters of 14 tablets
  • Carton box containing 4 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 3 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 6 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 2 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 4 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 3 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 7 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 7 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 1 Alu-Alu-foil blisters blisters of 14 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 07-4741
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0126/003
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • Finland
  • France
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 8/04/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 6/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 6/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."